[Acute complications of coronary angioplasty: prevention and management].

Abstract

The immediate results of transluminal coronary angioplasty (TCA) have improved considerably during recent years. Balloon dilatation of the arterial stenosis is the basis of this technique of revascularisation but new tools may be used to treat specific lesions. Coronary occlusion is the most feared complication of TCA. It may cause myocardial infarction or death of the patient. It is usually secondary to dissection and/or thrombus of the artery. The implantation of a stent successfully treats most cases of dissection. New anti-platelet (GP IIb/IIIa) drugs seem to be very effective in the prevention and treatment of the thrombosis. The systematic use of ticlopidine limits the risk of stent occlusion. Improved features enable satisfactory implantation of stents in the majority of cases. In some patients, the clinical consequences of occlusion may be limited by vascular bypass techniques, especially intra-aortic balloon pumping. In other cases, emergency coronary bypass surgery may be necessary. When TCA is considered to be a very high risk procedure, effective surgical cover is essential.

• Authors: J L Bonnet, A Avran, J Quilici, L Fourcade, M Bory
• Journal: Archives des maladies du coeur et des vaisseaux (Arch Mal Coeur Vaiss) Vol. 92 Issue 11 Suppl Pg. 1571-8 (Nov 1999) ISSN: 0003-9683 [Print] France
• Vernacular Title: Complications aiguës de l'angioplastie coronaire: prévention et prise en charge.
• PMID: 10598237 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Platelet Aggregation Inhibitors
• Ticlopidine

Topics

• Angioplasty, Balloon, Coronary (adverse effects)
• Coronary Artery Bypass
• Coronary Disease (etiology)
• Coronary Thrombosis
• Humans
• Intraoperative Complications (prevention & control, therapy)
• Myocardial Infarction
• Myocardial Revascularization (methods)
• Platelet Aggregation Inhibitors (therapeutic use)
• Stents
• Ticlopidine (therapeutic use)